Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Auto rebalancing and capital gains management covers how automated tweaks can curb tax impact while preserving strategy.
28,655 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
PI tumbled again as conference buzz fades and the project presses ahead with roadmap milestones. Analysts frame it as...
Wedbush raises Apple’s price target to $400, arguing a coming AI shift could position Apple as the main AI distributi...
Bitcoin steadies in the upper $77,000s as markets weigh renewed U.S.-Iran talks. Oil prices and Fed pricing will dete...
Hotter weather is pushing up electricity bills this summer, with analysts warning rate pressures may persist through ...
Sellers turning to private listings may avoid public exposure, but new data suggests this approach can lead to lower ...
Walmart reports a stronger holiday quarter as wealthier shoppers joined the rush, lifting overall sales and online gr...
A coalition of about 1,000 foundations unveils a nationwide effort to remind Americans how charities support communit...
The FTC and 11 states reached a $100 million settlement with Walmart over alleged wage and tip-disclosure violations ...
Adobe and LinkedIn launch a free upskilling program for marketers as AI demand climbs, featuring four concise tracks ...
The United States and its allies launched targeted strikes against facilities tied to Iran's leadership, triggering r...
Oil could move through strait hormuz before fertilizer shipments restart, signaling a rare reopening of the chokepoin...